EUVIMEDEUVIMED entdecken
Systematische Übersicht

Fertility-sparing management of low-grade endometrial stromal sarcoma: A systematic review of oncologic and reproductive outcomes

Giuseppe Cucinella, Maria Cristina Solazzo, Mariano Catello Di Donna, Carlo Ronsini, Federica Anzelmo Sciarra, Stefano Restaino, Vito Andrea Capozzi, Roberto Beretta, Giorgio Bogani, Cono Scaffa, Giuseppe Vizzielli, Vito Chiantera

European Journal of Surgical Oncology · 2025

DOI: 10.1016/j.ejso.2025.110382 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Giuseppe Cucinella und 11 weiteren Autor:innen. Beteiligte Einrichtung: Gynecology Oncology Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy. Electronic address: giuseppe.cucinella@istitutotumo…. Hauptthemen laut MEDLINE: Fertility Preservation, Endometrial Neoplasms, Sarcoma, Endometrial Stromal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Low-grade endometrial stromal sarcoma (LG-ESS) is a rare malignancy and the standard of care, precludes future childbearing. Although fertility-sparing treatment (FST) may be considered in carefully selected patients, high-quality evidence regarding its efficacy and safety is limited. This review aims to systematically evaluate the oncologic and reproductive outcomes associated with conservative treatment for LG-ESS. METHODS: Pubmed Database, Scopus Database and Embase Database were screened in September 2024 from the first publication about women with LG-ESS treated with a surgical FST. We included the studies containing data about oncologic, and reproductive outcomes. This study adheres to PRISMA guidelines and is registered with PROSPERO (CRD42024605140). The quality of the studies was assessed using the Newcastle-Ottawa scale. RESULTS: 9 studies fulfilled inclusion criteria, and 89 patients were analyzed. Recurrence was observed in 51 out of 89 patients (57.3 %) with a mean recurrence-free interval ranging between 3 and 40.5 months. A mortality rate of 1.1 % was observed, with a mean follow-up duration ranging from 38.5 to 84.5 months. The overall pregnancy rate was 41.5 % and the live birth rate was 78.1 %. The preterm delivery rate was 8 % and 3.9 % of patients required assisted reproduction technology. CONCLUSIONS: Considering the limitations of the available evidence, FST in women with LG-ESS carries a relatively high risk of tumor relapse, though it does not increase the risk of death. Fertility outcomes seem to be encouraging. Resection of the malignant uterine lesion combined with adjuvant hormonal treatment may be considered for selected early-stage patients, with close follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fertility PreservationEndometrial NeoplasmsSarcoma, Endometrial StromalHumansFemalePregnancyNeoplasm GradingPregnancy RateNeoplasm Recurrence, Local

Stichwörter der Autor:innen

Endometrial stromalFertility preservationPregnancy outcomeSarcomaUterine neoplasms

Autor:innen und Institutionen

  • Gynecology Oncology Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy. Electronic address: giuseppe.cucinella@istitutotumori.na.it.
  • Unit of Gynaecology and Obstetrics, Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", 80138, Naples, Italy.
  • Gynecology Oncology Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy.
  • Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy; PhD School in Biomedical Sciences, Gender Medicine, Child and Wom…
  • Obstetrics and Gynaecology Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Zitieren

APA

Cucinella, G., Solazzo, M. C., Di Donna, M. C., Ronsini, C., Sciarra, F. A., Restaino, S., Capozzi, V. A., Beretta, R., Bogani, G., Scaffa, C., Vizzielli, G., & Chiantera, V. (2025). Fertility-sparing management of low-grade endometrial stromal sarcoma: A systematic review of oncologic and reproductive outcomes. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110382

Vancouver

Cucinella G, Solazzo MC, Di Donna MC, Ronsini C, Sciarra FA, Restaino S, et al. Fertility-sparing management of low-grade endometrial stromal sarcoma: A systematic review of oncologic and reproductive outcomes. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.110382

BibTeX
@article{Cucinella2025,
  author = {Cucinella, Giuseppe and Solazzo, Maria Cristina and Di Donna, Mariano Catello and Ronsini, Carlo and Sciarra, Federica Anzelmo and Restaino, Stefano and Capozzi, Vito Andrea and Beretta, Roberto and Bogani, Giorgio and Scaffa, Cono and Vizzielli, Giuseppe and Chiantera, Vito},
  title = {Fertility-sparing management of low-grade endometrial stromal sarcoma: A systematic review of oncologic and reproductive outcomes},
  journal = {European Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1016/j.ejso.2025.110382}
}
Kostenlos starten →